Homing In On Genetic Signature Of Esophageal Cancer

Saturday, Jan. 7th 2012 6:40 AM

University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes. The study, led by Tony Godfrey, Ph.D., a research associate professor of Surgery at the James P.

Posted on Saturday, Jan. 7th 2012 6:40 AM | by Share of Cost | in Share of Cost | Comments Off on Homing In On Genetic Signature Of Esophageal Cancer